VICENTE DAMIÁN
ESCUDERO VILAPLANA
Profesor asociado de Ciencias de la Salud
C.
Villanueva Bueno
Publicaciones en las que colabora con C. Villanueva Bueno (16)
2024
-
Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient
Journal of Oncology Pharmacy Practice
2023
-
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 2855-2882
-
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Frontiers in Oncology, Vol. 13
-
Possible heart failure caused by osimertinib in a lung cancer patient
Journal of Oncology Pharmacy Practice, Vol. 29, Núm. 4, pp. 1015-1020
2022
-
A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital
Frontiers in Public Health, Vol. 10
-
Implantación de una metodología para evaluar patient‑reported outcomes en pacientes con cáncer de pulmón: Protocolo del estudio PeOpLe (Patient‑reported Outcomes in Lung cancer )
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 4, pp. 265-269
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
-
Medication guide for the perioperative management of oral antineoplastic agents in cancer patients
Expert Opinion on Drug Safety, Vol. 21, Núm. 1, pp. 107-119
-
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale
JMIR mHealth and uHealth, Vol. 10, Núm. 2
-
Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientes
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 173-181
-
Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients
Journal of Oncology Pharmacy Practice, Vol. 28, Núm. 5, pp. 1259-1263
-
Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App
Frontiers in Oncology, Vol. 12
2021
-
Acute pancreatitis in a patient treated with imatinib and gefitinib
Journal of Oncology Pharmacy Practice, Vol. 27, Núm. 4, pp. 980-983
-
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
International Journal of Antimicrobial Agents, Vol. 57, Núm. 2
-
Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice
Expert Opinion on Drug Metabolism and Toxicology, Vol. 17, Núm. 12, pp. 1467-1473
2020
-
Features and functionalities of smartphone apps related to COVID-19: Systematic search in app stores and content analysis
Journal of Medical Internet Research, Vol. 22, Núm. 8